| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Pathology Department, Royal Victoria Infirmary, University of Newcastle, Queens Victoria Road, Newcastle upon Tyne, NE1 4PH, UK
2 Cancer Research Unit, University of Newcastle
3 Paediatric Oncology Department, University of Newcastle
4 Haematology Department, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK
Correspondence to:
Dr J J Anderson, Pathology Department, Royal Victoria Infirmary, University of Newcastle, Queens Victoria Road, Newcastle upon Tyne, NE1 4PH, UK;
j.j.anderson{at}ncl.ac.uk
Background/Aims: p33ING1b is a tumour suppressor protein involved in growth control and apoptosis. Suppression of p33ING1b expression is associated with the loss of cellular growth control and immortalisation, whereas its overexpression causes cell cycle arrest. Moreover, normal p33ING1b expression is essential for optimal function of p53. Acute lymphoblastic leukaemia (ALL) is the most common malignancy of childhood, accounting for one third of all childhood malignancies. A variety of cytogenetic abnormalities have been described but there is no single abnormality common to all cases. Deregulation of the TP53 pathway is a common genetic abnormality in human malignancies. However, TP53 mutations are uncommon in ALL. It is possible that alternative mechanisms of regulation of the TP53 apoptosis pathway, such as modulation of p33ING1b expression, may be important in ALL. The aim of this study was to assess the expression of p33ING1b in childhood ALL.
Methods: One hundred and forty five patients with childhood ALL were investigated in this immunohistochemical study of the expression of p33ING1b.
Results: Loss of nuclear expression of p33ING1b was seen in 78% of cases. This was associated with increased cytoplasmic expression of the protein. Kaplan Meier survival analysis demonstrated a trend towards a better prognosis for patients with tumours that had lost nuclear p33ING1b.
Conclusion: These results suggest that the loss of nuclear p33ING1b expression may be an important molecular event in the pathogenesis of childhood ALL.
Keywords: ING1; p33ING1b; p53; leukaemia
Abbreviations: ALL, acute lymphoblastic leukaemia; B-ALL, B cell acute lymphoblastic leukaemia; ING1, inhibitor of growth 1; RB, retinoblastoma gene; T-ALL, T cell acute lymphoblastic leukaemia; TBS, Tris buffered saline; WBC, white blood cell
This article has been cited by other articles:
|
|
 |
|
  Y. Wang, D. L. Dai, M. Martinka, and G. Li Prognostic Significance of Nuclear ING3 Expression in Human Cutaneous Melanoma Clin. Cancer Res., July 15, 2007; 13(14): 4111 - 4116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Gong, M. Russell, K. Suzuki, and K. Riabowol Subcellular Targeting of p33ING1b by Phosphorylation-Dependent 14-3-3 Binding Regulates p21WAF1 Expression Mol. Cell. Biol., April 15, 2006; 26(8): 2947 - 2954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Falt, M. Merup, G. Tobin, U. Thunberg, G. Gahrton, R. Rosenquist, and A. Wennborg Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia Blood, July 15, 2005; 106(2): 681 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H.Y. He, C. C. Helbing, M. J. Wagner, C. W. Sensen, and K. Riabowol Phylogenetic Analysis of the ING Family of PHD Finger Proteins Mol. Biol. Evol., January 1, 2005; 22(1): 104 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Vieyra, D. L. Senger, T. Toyam, H. Muzik, P. M. A. Brasher, R. N. Johnston, K. Riabowol, and P. A. Forsyth Altered Subcellular Localization and Low Frequency of Mutations of ING1 in Human Brain Tumors Clin. Cancer Res., December 1, 2003; 9(16): 5952 - 5961. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |
